IRIS - Res&Arch Institutional Research Information System - Research & Archive

NIZI, MARIA GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 557
AS - Asia 394
EU - Europa 382
SA - Sud America 62
Continente sconosciuto - Info sul continente non disponibili 55
AF - Africa 11
OC - Oceania 1
Totale 1.462
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 533
SG - Singapore 169
IT - Italia 154
VN - Vietnam 56
CN - Cina 54
RU - Federazione Russa 54
HK - Hong Kong 49
IE - Irlanda 47
BR - Brasile 42
FR - Francia 21
KR - Corea 21
BE - Belgio 17
DE - Germania 16
GB - Regno Unito 14
CA - Canada 13
SE - Svezia 13
FI - Finlandia 9
NL - Olanda 8
IN - India 7
PL - Polonia 7
AR - Argentina 6
AT - Austria 6
MX - Messico 6
BD - Bangladesh 5
IQ - Iraq 5
JP - Giappone 5
UA - Ucraina 5
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
EC - Ecuador 4
ZA - Sudafrica 4
CO - Colombia 3
PH - Filippine 3
PK - Pakistan 3
SA - Arabia Saudita 3
TN - Tunisia 3
UZ - Uzbekistan 3
VE - Venezuela 3
EE - Estonia 2
ID - Indonesia 2
PY - Paraguay 2
RO - Romania 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
CL - Cile 1
CR - Costa Rica 1
CU - Cuba 1
DM - Dominica 1
ES - Italia 1
IR - Iran 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MT - Malta 1
NP - Nepal 1
PA - Panama 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 1.408
Salva come PNG Salva come JPEG
Città #
Singapore 130
Perugia 93
San Jose 65
Chandler 56
Ashburn 51
Dublin 47
Hong Kong 43
Boardman 27
Santa Clara 26
Dong Ket 20
Seoul 20
Moscow 19
Los Angeles 18
West Jordan 18
Brussels 17
The Dalles 17
Ho Chi Minh City 16
Council Bluffs 15
New York 14
Lauterbourg 11
San Mateo 10
Beijing 9
Hefei 8
Piscataway 8
Buffalo 7
Redmond 7
Hanoi 6
Helsinki 6
Phoenix 6
Lawrence 5
Medford 5
Milan 5
Princeton 5
Warsaw 5
Abidjan 4
Atlanta 4
Columbus 4
Dallas 4
Hanover 4
Nuremberg 4
Tokyo 4
Vienna 4
Altamura 3
Baghdad 3
Da Nang 3
Denver 3
Houston 3
Johannesburg 3
Norwalk 3
Olomouc 3
Rio de Janeiro 3
Riverbank 3
Rome 3
San Francisco 3
Secaucus 3
São Paulo 3
Turku 3
Amsterdam 2
Ankara 2
Brooklyn 2
Bucha 2
Campegine 2
Campinas 2
Chicago 2
Florence 2
Fremont 2
Genova 2
Guangzhou 2
Guayaquil 2
Haiphong 2
Itajaí 2
Jackson 2
Lahore 2
London 2
Manchester 2
Medellín 2
Monte Grande 2
Montreal 2
Munich 2
Nossa Senhora das Dores 2
Padova 2
Passo Fundo 2
Philadelphia 2
Phủ Lý 2
Porto Seguro 2
Riyadh 2
Romola 2
Stockholm 2
Tashkent 2
Toronto 2
Xian 2
Ahome 1
Andover 1
Antipolo City 1
Ardabil 1
Arroyo de La Ventana 1
Aryanah 1
Asheboro 1
Asunción 1
Balanga 1
Totale 969
Salva come PNG Salva come JPEG
Nome #
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 212
[1,2,4]Triazolo[3,4-b]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes 168
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 149
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 118
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions 116
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 107
Privileged Scaffolds for Potent and Specific Inhibitors of Mono-ADP-Ribosylating PARPs 106
Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15 94
Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules 88
Compounds for use in the treatment of cancer and inflammatory conditions 87
Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity 81
Synthetically accessible de novo design using reaction vectors: Application to PARP1 inhibitors** 64
A medicinal chemistry overview of direct-acting antivirals approved in 2013–2024 by US FDA 30
Optimization of 2,3-dihydrophthalazine-1,4-dione PARP inhibitor scaffold for nanomolar potency and specificity towards human PARP10 21
2-Phenylquinolines Exhibit Anti-Severe Acute Respiratory Syndrome Coronavirus-2 Activity Through the Nonstructural Protein 13 Helicase Inhibition 21
Totale 1.462
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.461
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.461
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202251 0 0 0 4 4 1 14 10 5 3 5 5
2022/2023146 5 20 1 23 18 14 0 8 46 5 4 2
2023/2024155 7 22 8 8 9 11 25 0 10 22 8 25
2024/2025322 5 22 4 28 22 25 81 21 40 29 30 15
2025/2026593 34 38 31 70 78 57 86 41 69 53 26 10
2026/2027126 17 39 48 22 0 0 0 0 0 0 0 0
Totale 1.462